The specific role of nicotinamide adenine dinucleotide (NAD) in hepatic triglyceride (TG) accumulation in alcoholic fatty liver disease (AFLD) were unclear.
Introduction
Alcoholic fatty liver disease (AFLD) is one of the most prevalent forms of chronic liver disease worldwide and has a widespread incidence. It may progress to alcoholic liver disease (ALD) which is a major cause of illness and death in the United States [1, 2] . The pathogenesis of AFLD is not well established. It was associated with excessive ethanol consumption which causes hepatic lipid accumulation, enhanced hepatic lipogenesis and inhibits the fatty acid oxidation [3] .
AFLD can progress to hepatitis, fibrosis, cirrhosis, which may become hepatocelluar carcinoma and liver-related death. But the mechanisms of AFLD are complicated and remain incompletely understood.
Chronic alcohol consumption enhanced lipogenesis and decreased fatty acid oxidation which destroyed the balanced of intracellular fatty metabolism. Alcohol exposure induced the generation of reactive oxygen species (ROS) which caused oxidative stress and lipid accumulation in liver [4] . Excessive alcohol consumption reduced the hepatic nicotinamide adenine dinucleotide (NAD + ) level, which disrupted the balance of NAD + /NADH radio and the elevation of the lactate/pyruvate ratio [5] .
Ethanol metabolism mediated cellular redox status and disturbed several major hepatic lipid metabolism transcriptional regulators, such as sterol regulatory element binding protein 1c (SREBP-1c), lipin-1, AMP-activated kinase (AMPK), Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), and Forkhead box protein O1 (FOXO1) [6] [7] [8] .
Poly ADP ribose polymerase (PARP) is an abundant nuclear protein that plays key roles in a variety of cellular processes, including transcriptional regulation and DNA repair and programmed cell death. It detects and initiates an immediate cellular response to single-strand DNA breaks (SSB) by signaling DNA-repairing enzymes to SSB repair. It is composed of four domains: a DNA-binding domain, a caspase-cleaved domain, an auto-modification domain, and a catalytic domain [9] . As one of the NAD + consumers (Sirtuins, PARPs, and CD38), PARP catalyzed the synthesis of polymeric adenosine diphosphate ribose (pADPr) from NAD + to the target proteins, thereby regulating their activity [10] . Excessive hyperactivation of PARP caused the depletion of intercellular NAD + and ATP levels, which led to cellular metabolistic disorder and death. Inhibition of PARP activity promoted atherosclerotic plaque regression, attenuated high-fat diet-induced dysfunction of lipid metabolism and diabetes [11] [12] . But the specific role of PARP in AFLD progression was not well investigated.
This study aimed to investigate the effect of PARP inhibitor PJ34 on hepatic lipid accumulation induced by chronic alcohol feeding and the underlying mechanism. We found that PJ34 attenuated hepatic NAD 
Materials and Methods

Animal and treatment
Male C57BL/6 mice (8 weeks) weighting 20 ± 0.5 (SD) g were obtained from the Harbin Medical University Experimental Animal Center. All studies were approved by the animal Ethical Committee of Harbin Medical University, Daqing, China. The mice were housed in conventional conditions, maintained on a 12 h light/dark cycle, temperature 23 ± 2 , humidity ℃ 50 ± 5% and fed standard food and water ad libitum at the animal facility for 1 week before experiment began. All mice were fed for 4 weeks with liquid diets. All diets were purchased from Research Diets Inc (TROPHIC Animal Feed High-Tech, China). Pair-fed diet (TP 4030A, PF) contains 18% protein, 35% fat, 47% carbohydrate and alcohol-fed diet (TP 4030C, AF) contains 18% protein, 35% fat, 11% carbohydrate and 36% alcohol according to Lieber-DeCarli [13] . Forty-five male C57BL/6 mice were then randomly divided into six groups and were fed on respective diets for model development. The groups included: (1) PF + physiologic saline (PF, n=6), (2) PF+ PJ34, (n =6), (3) PF+ nicotinamide riboside (NR, Hangzhou LZ Chemical, China) (n=6); (4) AF + physiologic saline (AF, n=9), (5) AF+PJ34 (n =9), (6) AF+NR (n=9). Treatment: PJ34
as a PARP activity specific inhibitor (10mg/kg/day, Selleck Chemicals, USA) was injected intraperitoneally 3 times a week throughout the experiment. The same volume of physiologic saline ((0.1 ml/20g/day i.p.) was injected intraperitoneally 3 times a week as vehicle-treated. NR as a natural NAD + precursor (10mg/kg/day) was supplemented in the liquid diet throughout the experiment. Food consumption was recorded daily. Mice were weighted weekly on the same day. All animal was sacrificed after an overnight fast. At the end of the experiment, plasma, liver samples and epididymal fat pad samples were harvested.
Histological analysis
The liver samples were fixed in 4% paraformaldehyde for 2 days, transferred to 70% ethanol, dehydrated through a serial alcohol gradient, the tissues were embedded in paraffin wax block and cut into 6 µm thin sections. All sections were dewaxed in xylene, rehydrated through decreasing concentrations of ethanol, and washed in distilled water. Finally, tissue sections were stained with hematoxylin and eosin (H&E). The fields were randomly selected and were photographed under ×400 magnification.
Circulating biochemical measurement
The levels of circulating TG, total cholesterol (TC) and alanine transaminase 
Hepatic TG and TC measurement
The liver tissues were washed by PBS for 2 times. 800 mg liver tissue was homogenized in 1 ml 50 mM NaCl. Liver total lipids were extracted in 7 ml heptanes : isopropanol (3:2) mixture at room temperature in shaking stable for 2 h. They were centrifuged at 3,000×g for 5 min. The organic layer was collected to a new tube and dried under a stream of air in the hood. Liver TG content was determined by commercially available kit as described previously.
Cell Culture and treatment
HepG2 cells, a human hepatoma cell line, were purchased from the Institute for biological sciences (Shanghai, China). HepG2 cells were cultured in DMEM high glucose culture fluid (Gibco Company, USA) containing 10% (v/v) FBS, supplemented with 2 mM glutamine, 100 IU/ml penicillin and 100 mg/ml streptomycin. They were incubated at 37 °C in a humidified incubator with 5% CO2
and 95% air. For pharmacological studies, cells were washed with phosphate-buffered saline (PBS) 3 times and replaced with serum-free medium for serum starvation. After 12 h culture, they were treated with PARP inhibitor, PJ34 (1 µM) in the absence or presence of Oleic Acid (3.3 µM, OA, Sigma, USA) for 24 h. The same volume of serum-free medium acted as the control group.
Intracellular TG Determination
After treatment with PJ34 in presence OA for 24 h, cells harvested at the end of the experiment. For intracellular TG measurement, HepG2 cells were dissolved in 0.3 ml NaOH (50 mM) solution per well (24 well plate). Hepatic total lipids were extracted in 1ml heptanes : isopropanol (3:2) mixture at room temperature in shaking stable for 2 h. They were centrifuged at 3,000×g for 5 min. The organic layer was collected to a new tube and dried under a stream of air in the hood. Hepatic TG content was determined by commercially available kit as described previously.
Hepatic and Intracellular NAD + analysis
Liver tissue samples and intracellular NAD 
Western blot analysis
Cells were washed three times with PBS and lysed in RIPA buffer (50 mM Tris Secondary antibodies used were: goat anti-mouse and anti-rabbit horseradish peroxidase-conjugated (ZSGB-BIO, China). Peroxidase was detected using enhanced chemiluminescence (ECL) Western blotting detection reagents (Haigene, China).
Densitometric analysis was performed using Quantity One software (Bio-rad, USA).
RNA Extraction and Real-time PCR Assays
Total RNAs were extracted from liver tissues or HepG2 cells. Total RNAs were the target genes, all primers were purchased from Genscript Biotechnology (Nanjing, China). Quantitative normalization of the cDNA in each sample was performed using the 18s rRNA gene as an internal control. Real-time PCR assays were performed in duplicate for each sample, and the mean value was used for the calculation of mRNA expression levels.
Statistical analysis
Statistical analysis was performed using one-way analysis of variance and Newman-keuls test by OriginPro7.5 software (OriginLab company, Austin, USA) and Graph Pad Prism version 5 (Graph Pad Software Inc. San Diego,California). Data were presented as the mean ± standard error. Values of P < 0.05 were considered to indicate a statistically significant difference.
Results
Chronic Alcohol Consumption induced hepatic fat accumulation and liver injury in mice
C57BL/6 mice were fed with Lieber-DeCarli alcohol-containing diet for 4 weeks.
Liver samples were harvested for histological examination and the hepatic TG content was detected. As shown in our results, chronic alcohol feeding significantly decreased body weight and epididymal fat pad weight/body weight rate ( Figure 1A ,C) in comparison to PF group, whereas the liver weight/body weight rate was significantly increased ( Figure 1B ). Chronic alcohol consumption increased hepatic TG content and circulating TG level ( Figure 1E,F) . Chronic alcohol exposure increased circulating ALT level ( Figure 1D ) and hepatic TC level ( Figure 1G ). The severity of AFLD was analyzed by staining with H&E staining (Figure 1I , ×400). In the AF group, the lobular structures was destroyed and widely distributed, with more lipid droplets when compared with the PF group. The data showed that chronic alcohol consumption induced hepatic lipid accumulation and liver injury. 
Chronic alcohol feeding enhanced PARP expression, pADPr synthesis and NAD + depletion in mice
After feeding with ethanol-containing liquid diet for 4 weeks, liver samples were harvested for further experiment. Total proteins were extracted from liver samples.
Western blot was used to detect PARP expression and activation in alcohol-fed mice.
Our results showed that chronic alcohol feeding elevated PARP protein expression (Figure 2A,B) and activity, which was showed by higher pADPr conjugated with proteins ( Figure 
Inhibition of PARP activity increased NAD + level and lowered intracellular TG content in hepatocyte
The HepG2 cells were used to investigate whether PARP inhibition modulated hepatic lipid accumulation and the underlying mechanism. As shown in our results, PJ34 exposure (1 μM) for 24 h decreased pADPr synthesis ( Figure 3C ) but had no effect on the protein abundance of PARP ( Figure 3A ,B) in hepatocyte. Furthermore, we found that intracellular NAD 
Inhibition of PARP activity suppressed the expression of the genes in TG anabolism
To gain insight into the mechanism underlying PJ34 decreased intracellular TG accumulation, HepG2 cells were exposed to PJ34 ( 
PJ34 injection attenuated hepatic TG accumulation in alcohol feeding mice
To detect the specific role of PARP inhibition in the pathogenesis of AFLD, C57BL/6 mice were exposed to alcohol-containing liquid diet with/without PJ34 intraperitoneal injection for 4 weeks. As shown in our results, PJ34 injection increased body weight ( Figure 5A ) and decreased the liver weight/body weight rate ( Figure 5B ), but the epididymal fat pad weight/body weight rate had no significant change ( Figure   5C ) compared with the AF group. Moreover, PJ34 injection decreased hepatic TG content and circulating TG level in comparison to the AF group ( Figure 5E,F) . In our results, PJ34 injection had no roles in hepatic TC and circulating TC and ALT level in with H&E(×400) (I). The data are expressed as the mean±SD (n=6 per group); *p<0.05 compared to AF group. 
PJ34 injection elevated hepatic NAD
NR supplementation attenuated hepatic TG accumulation in alcohol feeding mice
To further demonstrate the specific role of NAD + in TG anabolism, C57BL/6 mice were fed with alcohol-containing liquid diet supplemented with NR for 4 weeks.
We found that NR supplementation increased body weight ( Figure 7A ) and decreased liver weight/body weight rate ( Figure 7B ) in comparison to AF group. And no significant change were observed in epididymal fat pad weight/body weight rate ( Figure 7C ) and hepatic TC content ( Figure 7E ) in alcohol-fed mice after NR supplementation. Importantly, NR supplementation elevated hepatic NAD + content ( Figure 7F ) and alleviated hepatic TG accumulation ( Figure 7D ) in alcohol-fed mice.
All the data suggest that elevating hepatic NAD + content by NR supplementation attenuated chronic alcohol consumption-induced hepatic TG accumulation. indicates significant differences compared to AF group.
Discussion
In the current study, we demonstrated that PARP inhibitor PJ34 alleviated TG accumulation in both hepatocyte and the liver of alcohol-fed mice and the underlying mechanism is involved in the PJ34-elevated NAD The similar consideration was seen in several current reports. PARP inhibitor olaparib improved hepatic fatty acid oxidation and NAFLD induced by HFHS-diet [18] . Pharmacological inhibition of PARP or genetic deletion of PARP1 can restored the hepatic NAD + content and increased SIRT1 activation, which decreased hepatic TG accumulation in both alcoholic and nonalcoholic steatohepatitis (ASH/NASH) [25] . In current investigation, we found that PJ34 injection for 4 weeks lowered both circulating TG and hepatic TG level in alcohol-fed mice, but no significant change was observed for circulating and hepatic TC level in the same conditions. The 
